PT. Penta Valent Tbk

PEVE

ID1000183601

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
260 ^IDR	+2.36%		-2.99%	+52.94%

04-30	PT. Penta Valent Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	PT. Penta Valent Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT. Penta Valent Tbk has filed an IPO in the amount of IDR 54.832 billion.

December 30, 2022 at 05:00 am

PT. Penta Valent Tbk has filed an IPO in the amount of IDR 54.832 billion.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 368,000,000
PriceRange: IDR 120 to IDR 149
Transaction Features: ESOP Related Offering

Latest news about PT. Penta Valent Tbk

PT. Penta Valent Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	04-30	CI
PT. Penta Valent Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
PT. Penta Valent Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
Certain Shares of PT. Penta Valent Tbk are subject to a Lock-Up Agreement Ending on 20-SEP-2023.	19/09/23	CI
PT. Penta Valent Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	30/07/23	CI
PT. Penta Valent Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	01/05/23	CI
PT. Penta Valent Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23	CI
PT. Penta Valent Tbk has completed an IPO in the amount of IDR 52.615625 billion.	19/01/23	CI
PT. Penta Valent Tbk has filed an IPO in the amount of IDR 54.832 billion.	30/12/22	CI

Chart PT. Penta Valent Tbk

Duration

Period

More charts

Company Profile

PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment and consumer products. The pharmaceutical products or medicines and medical devices distributed by the Company are divided into several types, including ethical products, which are medicines sold in limited quantities and require a doctorâs prescription; Over The Counter products, which are medicines sold freely; Medical Devices, which are medical supporting devices such as blood pressure monitors, nebulizer, kateter, and others; Reagents, which are reaction materials such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, and others; as well as Food Supplements. Its distribution of consumer goods, which is divided into two types of products, namely Cosmetics: products for beauty and skin care, including makeup, perfume, skin nutrition, and others; and Toiletries: products for daily cleanliness and hygiene such as soap, shampoo, toothpaste, lotion, and other.

Sector

Pharmaceuticals

Calendar

28/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
PT. PENTA VALENT TBK	+52.94%	28.08M
MCKESSON CORPORATION	+26.15%	75.76B
CARDINAL HEALTH, INC.	-2.46%	23.95B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.23%	8.7B
SINOPHARM GROUP CO. LTD.	+1.47%	8.29B
HUADONG MEDICINE CO., LTD	-32.92%	6.7B
H. LUNDBECK A/S	+18.62%	5.38B
GALENICA AG	+1.10%	4.08B
EBOS GROUP LIMITED	-9.24%	3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-10.20%	3.3B